The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test.

Yo-Yo test hematology hematopoietic stem cell transplantation leukemia lymphoma pediatric performance precision-based exercise

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 Feb 2022
Historique:
received: 18 01 2022
revised: 21 02 2022
accepted: 23 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

During cancer treatments in childhood hematological malignancies, reduced exercise tolerance is one of the main hardships. Precision-based training programs help children, adolescents, and young adults and their families to resume regular physical activity, exercise, and sports once they return to their communities after the intensive phases spent in hospital. This study was aimed at verifying whether an intermittent recovery test, the Yo-Yo AD, could provide a simple and valid way to evaluate an individual’s capacity to perform repeated intense exercise and to follow up on the impact of tailored exercise in children, adolescents, and young adults with hematological malignancies. The Yo-Yo AD involved the repetition of several shuttles to muscle exhaustion, at pre-established speeds (walking and slow running). The heart rate (HR) and oxygen saturation (SaO2) were monitored during the test. The total distance and the walking/running ability, measured as the slope of the HR vs. distance correlation, were investigated before (T0) and after 11 weeks (T1) of precision exercise intervention. The Yo-Yo AD was also performed by healthy children (CTRL). Ninety-seven patients (10.58 ± 4.5 years, 46% female) were enrolled. The Yo-Yo AD showed the positive impact of the exercise intervention by increasing the distance covered by the individuals (T0 = 946.6 ± 438.2 vs. T1 = 1352.3 ± 600.6 m, p < 0.001) with a more efficient walking/running ability (T0 = 2.17 ± 0.84 vs. T1 = 1.73 ± 0.89 slope, p < 0.0164). CTRLs performed better (1754.0 ± 444.0 m, p = 0.010). They were equally skillful (1.71 ± 0.27 slope) when compared to the patients after they received the precision-based intervention. No adverse events occurred during the Yo-Yo AD and it proved to be an accurate way of correctly depicting the changes in performance in childhood hematological malignancies.

Identifiants

pubmed: 35267495
pii: cancers14051187
doi: 10.3390/cancers14051187
pmc: PMC8909675
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Oncol. 2015 Dec 10;33(35):4134-7
pubmed: 26460301
Support Care Cancer. 2018 Jul;26(7):2177-2184
pubmed: 29383508
Leuk Lymphoma. 2015 Apr;56(4):1004-11
pubmed: 25030039
Med Pediatr Oncol. 1998 Apr;30(4):240-8
pubmed: 9473759
Med Pediatr Oncol. 2001 Mar;36(3):345-51
pubmed: 11241435
Pediatr Blood Cancer. 2016 Sep;63(9):1643-8
pubmed: 27145378
J Pediatr. 2007 Apr;150(4):395-9, 399.e1-2
pubmed: 17382117
Horm Res Paediatr. 2019;91(2):137-151
pubmed: 30481777
J Clin Oncol. 2007 Apr 20;25(12):1498-504
pubmed: 17442991
J Sports Sci Med. 2012 Sep 01;11(3):387-92
pubmed: 24149344
JAMA. 2013 Jun 12;309(22):2371-2381
pubmed: 23757085
Open Heart. 2021 Jun;8(1):
pubmed: 34083390
G Ital Nefrol. 2011 Nov-Dec;28(6):642-7
pubmed: 22167615
Med Pediatr Oncol. 1995 Apr;24(4):222-30
pubmed: 7700166
Eur J Cancer. 2007 Aug;43(12):1778-80
pubmed: 17543517
Med Sci Sports Exerc. 2007 Jan;39(1):13-21
pubmed: 17218878
J Pediatr Hematol Oncol. 2014 Nov;36(8):594-8
pubmed: 25330012
Ann Oncol. 1997;8 Suppl 1:19-24
pubmed: 9187424
Pediatr Blood Cancer. 2007 Oct 15;49(5):699-703
pubmed: 17420991
Sports Med. 2017 Aug;47(8):1457-1465
pubmed: 28074412
Sports Med. 2008;38(1):37-51
pubmed: 18081366
Pediatr Blood Cancer. 2012 Jul 15;59(1):96-9
pubmed: 21858914
Pediatr Phys Ther. 2004 Summer;16(2):90-8
pubmed: 17057533
Leukemia. 2001 May;15(5):728-34
pubmed: 11368432
Eur J Appl Physiol. 2013 Feb;113(2):325-35
pubmed: 22711181
Sci Rep. 2020 Jul 30;10(1):12892
pubmed: 32733066
Int J Sports Med. 2008 Feb;29(2):163-7
pubmed: 17879894
PLoS One. 2014 Dec 05;9(12):e114273
pubmed: 25479403
Haematologica. 2013 Jul;98(7):1089-97
pubmed: 23645686
Lancet Oncol. 2012 Sep;13(9):906-15
pubmed: 22901620
Pediatr Blood Cancer. 2020 Dec;67(12):e28687
pubmed: 33044779
Chest. 2011 Oct;140(4):881-901
pubmed: 21415131
J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):115-24
pubmed: 26136187
Blood. 2008 Jun 15;111(12):5515-23
pubmed: 18334672
Pediatr Hematol Oncol. 2016 Sep;33(6):393-407
pubmed: 27690707
Circulation. 2018 Mar 13;137(11):1176-1191
pubmed: 29530893
Scand J Med Sci Sports. 2020 Jan;30(1):126-134
pubmed: 31482597
Eur J Cancer Care (Engl). 2021 Jul;30(4):e13418
pubmed: 33523541
Curr Sports Med Rep. 2020 Jun;19(6):223-231
pubmed: 32516193
Sports Med. 2008;38(4):297-316
pubmed: 18348590
Med Sci Sports Exerc. 2010 Jun;42(6):1045-53
pubmed: 19997035
Med Sci Sports Exerc. 2017 Feb;49(2):223-230
pubmed: 27631396
Front Pediatr. 2020 Jun 05;8:243
pubmed: 32582585
Eur J Cancer. 2018 Oct;102:69-81
pubmed: 30138773
PLoS One. 2014 Jun 23;9(6):e99282
pubmed: 24956391
Cancer. 2008 Apr 15;112(8):1835-44
pubmed: 18311782
Phys Ther. 2008 Mar;88(3):341-50
pubmed: 18202079

Auteurs

William Zardo (W)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Emanuele Villa (E)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Eleonora Corti (E)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Tommaso Moriggi (T)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Giorgia Radaelli (G)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Alessandra Ferri (A)

Institute for Health and Sport, Victoria University, Melbourne 3011, Australia.

Mauro Marzorati (M)

Institute of Biomedical Technologies, National Research Council, 20054 Segrate, Italy.

Cristiano Eirale (C)

Paris Saint Germain Football Club, 78100 Paris, France.

Paola Vago (P)

Department of Pedagogy, Università Cattolica del Sacro Cuore, 20123 Milano, Italy.

Andrea Biondi (A)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Momcilo Jankovic (M)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Adriana Balduzzi (A)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Francesca Lanfranconi (F)

Maria Letizia Verga Center, Department of Pediatrics, Università degli Studi di Milano-Bicocca, ASST Monza/MBBM Foundation, 20900 Monza, Italy.

Classifications MeSH